Centessa Pharmaceuticals PLC - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Centessa Pharmaceuticals PLC - ADR
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
/ 
Frequently asked questions
To buy Centessa Pharmaceuticals PLC - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Centessa Pharmaceuticals PLC - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Centessa Pharmaceuticals PLC - ADR is CNTA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Centessa Pharmaceuticals PLC - ADR has its primary listing on NASDAQ. You can trade Centessa Pharmaceuticals PLC - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Centessa Pharmaceuticals PLC - ADR is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Centessa Pharmaceuticals PLC - ADR as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures - so you can make more informed decisions when considering shares like Centessa Pharmaceuticals PLC - ADR or others.